The Food and Drug Administration (FDA) advised consumers to avoid using the herb kratom, citing 36 known deaths associated with products containing the substance.
Kratom comes from a plant in Southeast Asia. It is used to treat pain, anxiety, depression, and symptoms of opioid withdrawal, The Washington Post reports.
It is also used recreationally, because it produces symptoms such as euphoria, the article notes.
“There is no reliable evidence to support the use of kratom as a treatment for opioid use disorder,” FDA Commissioner Scott Gottlieb said in a statement. “Patients addicted to opioids are using kratom without dependable instructions for use and more importantly, without consultation with a licensed health care provider about the product’s dangers, potential side effects or interactions with other drugs.”
The FDA noted that there have been reports of kratom being laced with other opioids like hydrocodone. The use of kratom is also associated with serious side effects like seizures, liver damage and withdrawal symptoms.
- Long-Acting and Daily Medications to Treat Opioid Addiction Found Equally Effective
- DEA Rule Allows Criminal Prosecution for Fentanyl Trafficking
- Teens Dependent on Marijuana and Alcohol Struggle with Success Later in Life
- Millions of Dollars Needed for Trump’s Anti-Opioid Ad Campaign, Advocates Say
- Combo of Acetaminophen and Ibuprofen as Effective as Opioids for Acute Pain
- Drug Overdose Deaths Rose More Than 17 Percent Last Year: CDC
- Hospitals Overwhelmed With Treating Diseases Resulting From IV Drug Use
- Teens Bring Juul E-Cigarette Device, Which Looks Like USB Flash Drive, to School
- NIAAA Alcohol Treatment Navigator: Pointing the Way to Quality Care
- DEA Collects Record Number Of Unused Pills As Part Of Its 14th Prescription Drug Take Back Day
- NIDA Launches Two Adolescent Substance Use Screening Tools
- Patients Treated with Naloxone Continue to be at High Risk of Overdose: Study
- New Rule Allows Health Providers to Share Information about Overdose with Family
- Addressing the Opioid Crisis Means Confronting Socioeconomic Disparities
- Drug Use Disorder vs. Drug Misuse - What is the Difference?
- NCADD Affiliate Executive Director Featured in NY Times Op Ed
- President’s Commission on Opioid Crisis Calls for Nationwide System of Drug Courts
- Fentanyl is Key Factor Driving Opioid Overdose Deaths: CDC
- Many Teens Who Take Adderall as “Study Drug” Unaware it is Amphetamine
- Giving Tuesday